ASSISTANT COMMISSIONER OF INCOME TAX, CIRCLE-1, AURANGABAD, AURANGABAD vs. EAST WEST SEEDS INDIA PRIVATE LIMITED, AURANGABAD
What did the Tribunal hold?
The Tribunal held that the disallowance of weighted deduction under Section 35(2AB) was not justified. Following its own prior decision in the assessee's own case for AY 2014-15 and the principles laid down in Cummins India Ltd. vs. Deputy Commissioner of Income Tax, the Tribunal ruled that the recognition of the R&D facility by the prescribed authority is crucial, and the AO cannot curtail the deduction based on partial certification in Form-3CL, especially prior to the 2016 amendment. The Tribunal found no merit in the Revenue's grounds of appeal on this issue and dismissed them. Regarding the alternate claim for deduction under Section 35(1)(iv)/37(1), the Tribunal found merit in the assessee's contention that if expenses are disallowed under Section 35(2AB), they should be considered for deduction under these sections. For AY 2017-18, the claim was restored to the AO for verification. Similarly, for AY 2018-19, the grounds related to Section 35(2AB) were dismissed, and the alternate claim under Section 35(1)(iv)/37(1) was allowed in terms of verification by the AO. For AY 2017-18, the claim for refund of excess DDT paid under the DTAAs was also restored to the AO for verification, following precedents. The disallowance of contribution to the Gratuity fund was confirmed by the CIT(A) and not challenged by the assessee before the Tribunal, hence it stood confirmed.
What were the facts?
The assessee, East West Seeds India Private Limited, is engaged in the business of producing and procuring seeds for sale in India and export markets. The appeals concern Assessment Years (AYs) 2016-17, 2017-18, and 2018-19. For AY 2016-17, the Assessing Officer (AO) disallowed Rs. 5,02,86,330/- claimed as weighted deduction under Section 35(2AB) of the Income Tax Act, 1961, based on a Form-3CL from DSIR, while allowing 100% of this amount under Section 35(1)(i)/37(1). The AO also disallowed Rs. 26,99,591/- towards contribution to a Gratuity Scheme. The Commissioner of Income Tax (Appeals) [CIT(A)] deleted the Section 35(2AB) disallowance, relying on a prior ITAT decision for AY 2014-15, but confirmed the gratuity fund disallowance. The Revenue appealed the deletion of the Section 35(2AB) disallowance. For AYs 2017-18 and 2018-19, similar issues arose regarding Section 35(2AB) deductions and alternate claims under Section 35(1)(iv)/37(1). Additionally, for AY 2017-18, the assessee claimed a refund of excess dividend tax paid under DTAAs.
What were the issues?
1. Whether the disallowance of weighted deduction under Section 35(2AB) of the Act, based on the DSIR's Form-3CL, is justified? (Question of law) - Assessee's contention: The assessee argued that the recognition of the R&D facility by the prescribed authority is the primary step, and the AO should allow expenditure incurred on in-house R&D as weighted deduction under Section 35(2AB). They relied on the ITAT's decision in their own case for AY 2014-15 and the case of Cummins India Ltd. vs. Deputy Commissioner of Income Tax, which held that prior to the 2016 amendment, no specific procedure for DSIR approval of expenditure year-to-year was prescribed, and the AO should not curtail deductions based on partial certification in Form-3CL. - Revenue's contention: The Revenue contended that the disallowance of weighted deduction under Section 35(2AB) was justified as it was based on the DSIR's Form-3CL, which indicated that only a part of the R&D expenses was eligible for weighted deduction. 2. Whether, if the weighted deduction under Section 35(2AB) is disallowed, the expenses incurred on in-house research ought to be allowed as a deduction under Section 35(1)(iv)/37(1) of the Act? (Question of mixed law and fact) - Assessee's contention: The assessee argued that if expenses are disallowed under Section 35(2AB), they should be allowed as a deduction under Section 35(1)(iv)/37(1). For AY 2017-18, the assessee also claimed a refund of excess dividend distribution tax (DDT) paid under the beneficial provisions of the India-Netherlands and India-Thailand DTAAs, relying on the decision in Piaggio Vehicles Private Limited vs. ACIT and M/s. Colorcon Asia Pvt. Ltd. - Revenue's contention: Not recorded for this issue. 3. Whether the disallowance of contribution to the LIC group Gratuity Scheme under Section 36(1)(v) r.w.s. 40A(9) of the Act is justified? (Question of law) - Assessee's contention: Not recorded for this issue. - Revenue's contention: The Revenue supported the AO's disallowance of the gratuity fund contribution.
Which sections of the Income-tax Act were involved?
Section 35(2AB),Section 35(1)(i),Section 37(1),Section 36(1)(v),Section 40A(9),Section 35(1)(iv)
AI-generated summary — verify with the full judgment below
Income Tax Appellate Tribunal, PUNE BENCH “A”, PUNE
Before: SHRI RAMA KANTA PANDA & Ms. ASTHA CHANDRA
IN THE INCOME TAX APPELLATE TRIBUNAL PUNE BENCH “A”, PUNE
BEFORE SHRI RAMA KANTA PANDA, VICE PRESIDENT AND Ms. ASTHA CHANDRA, JUDICIAL MEMBER ITA No. A.Y. Appellant Respondent Asst. Commissioner of East West Seeds India Income Tax, Circle-1, Private Limited, Income Tax Office, Gut No. 66, 961/PUN/2026 2016-17 Jeevan Suman LIC Narayanpur BK, Building, 2nd Floor, TQ Gangapur, CIDCO, Aurangabad Aurangabad [PAN: AABCE1237F] East West Seeds India 962/PUN/2026 2017-18 Private Limited, Gut No. 66, DCIT, Circle-1, Narayanpur BK, Aurangabad TQ Gangapur, 963/PUN/2026 2018-19 Aurangabad [PAN: AABCE1237F] Assessee by : Shri Nikhil Pathak Department by : Shri Mithun Shete, CIT-DR & Shri Rajesh Haladkar, Addl.CIT Date of Hearing : 19-08-2026 Date of Pronouncement : 05-11-2026 O R D E R PER ASTHA CHANDRA, J.M.:
ITA No. 961/PUN/2026 filed by the Revenue and ITA Nos. 962 & 963/PUN/2026 filed by the assessee are directed against the order(s) of the Ld. Commissioner of Income Tax (Appeals), NFAC, Delhi [“CIT(A)/NFAC”], u/s. 250 of the Income Tax Act, 1961 (the “Act”), dated 10-12-2025, 11-12-2025 and 11-12-2025 pertaining to Assessment Years (“AYs”) 2016-17, 2017-18 and 2018-19 respectively. Since common issues are involved, all these appeals were heard together and are being disposed of by this common order.
Revenue‟s appeal in ITA No. 961/PUN/2026 (AY. 2016-17): 2. Briefly stated, the facts of the case are that the assessee is a company engaged in the business of production and procurement of
2 East West Seeds India Private Limited vegetable, fruits and flower seeds from local as well as overseas markets and sells it in India as well as export market. For AY 2016-17, the assessee filed its return of income on 25-11-2016 declaring total income of Rs.11,99,92,803/- which was revised on 10-03-2017 declaring total income of Rs. 11,99,92,800/-. The case of the assessee was selected for scrutiny under CASS. Accordingly, statutory notices u/s. 143(2) and 142(1) of the Act along with questionnaire were issued and duly served upon the assessee, in response to which the assessee filed its reply from time to time. During the course of assessment proceedings, the Ld. Assessing Officer (“AO”) noted that during the year under consideration, the assessee has claimed weighted deduction of Rs. 26,39,90,660/- (i.e. 200%) on the Research and Development (“R&D”) expenses incurred of Rs. 13,19,95,330/- u/s. 35(2AB) of the Act for its approved R&D units. However, DSIR in Form-3CL mentioned the R&D revenue expenses less by Rs. 5,02,86,330/-. The Ld.AO, therefore, relying on the DSIR certificate in Form-3CL, disallowed expenses of Rs. 5,02,86,330/- as not eligible for weighted deduction u/s. 35(2AB) of the Act. However, the Ld.AO allowed 100% of Rs. 5,02,86,330/- u/s. 35(1)(i)/37(1) of the Act. He further disallowed the amount of Rs. 26,99,591/- contributed by the assessee to LIC group Gratuity Scheme u/s. 36(1)(v) r.w.s. 40A(9) of the Act. The Ld.AO accordingly completed the assessment at the assessed income of Rs. 17,29,78,721/-, thereby making addition of – i) Rs. 5,02,86,330/- on account of excess deduction claimed u/s.35(2AB) of the Act and ii) 26,99,591/- on account of disallowance of claim of contribution to Gratuity fund u/s. 36(1)(v) r.w.s. 40A(9) of the Act, vide his order dt. 30-12-2018 passed u/s. 143(3) of the Act.
Aggrieved, the assessee preferred an appeal before the Ld.CIT(A)/NFAC challenging the above additions made by the Ld.AO. The
3 East West Seeds India Private Limited Ld.CIT(A)/NFAC confirmed the addition made by the Ld.AO of Rs. 26,99,591/- on account of disallowance of claim of contribution to Gratuity fund u/s. 36(1)(v) r.w.s. 40A(9) of the Act. He, however, deleted the addition made by the Ld.AO on account of disallowance of weighted deduction of Rs. 5,02,86,330/- on the ground that the issue involved is identical to the assessee's own case for AY. 2014-15, wherein the Assessing Officer had disallowed excess deduction u/s 35(2AB) of the Act on the basis of Form 3CL issued by DSIR and the said disallowance was deleted by the Ld.CIT(A)/NFAC. On further appeal by the Revenue against the order of Ld.CIT(A)/NFAC, the Pune Tribunal dismissed the Revenue‟s appeal, vide its order in ITA No. 179/PUN/2018 dated 06-08-2019. The relevant observation and finding of the Ld.CIT(A)/NFAC is as under:
“6.1 Ground Nos. 1 & 2-Disallowance of weighted deduction u/s 35(2AB) The AO disallowed R&D expenditure of Rs. 50,28,63,30/- solely on the basis of Form 3CL issued by DSIR. In the appellant's own case for the AY 2014-15, the AO completed assessment u/s 143(3) determining the assessed income at Rs.12,19,22,711/- after disallowing excess deduction of Rs.3,60,18,330/- u/s 35(2AB) of the Income Tax Act, 1961, being 200% weighted deduction claimed against expenses of Rs. 1,80,09,165/- held ineligible by DSIR in the Form 3CL issued by it. In that case, being aggrieved, the appellant preferred an appeal before CIT (A). The Ld.CIT (A) had allowed deduction of Rs.3,60,18,330/- claimed by the appellant. The Hon'ble ITAT vide order in ITA No.179/PUN/2018 dated 06-08-2019, the Hon'ble ITAT, Pune had dismissed the appeal filed by revenue against the order of the Ld.CIT(A). The Hon'ble ITAT had relied on the decision in the case of Hon'ble ITAT, Pune in the case of Cummins India Ltd. Vs. Deputy Commissioner of Income Tax where in it was held that "45. The issue which is raised in the present appeal is that whether where the facility has been recognized and necessary certification is issued by the prescribed authority, the assessee can avail the deduction in respect of expenditure incurred on in- house R&D facility, for which the adjudicating authority is the Assessing Officer and whether the prescribed authority is to approve expenditure in form No.3CL from year to year. Looking into the provisions of rules, it stipulates the filing of audit report before the prescribed authority by the persons availing the deduction under section 35(2AB) of the Act but the provisions of the Act do not prescribe any methodology of approval to be granted by the prescribed authority vis-à-vis expenditure from year to year. The amendment brought in by the IT (Tenth Amendment) Rules w.e.f. 01.07.2016, wherein separate part has been inserted for certifying the amount of expenditure from year to year and the amended form No.3CL thus, lays down the procedure to be followed by the prescribed authority. Prior to the aforesaid amendment in 2016, no such procedure / methodology was prescribed. In the absence of the same, there is no merit in the order of Assessing Officer in curtailing the expenditure and
4 East West Seeds India Private Limited consequent weighted deduction claim under section 35(2AB) of the Act on the surmise that prescribed authority has only approved part of expenditure in form No.3CL. We find no merit in the said order of authorities below. approval to be granted by the prescribed authority vis-à-vis expenditure from year to year. The amendment brought in by the IT (Tenth Amendment) Rules w.e.f. 01.07.2016, wherein separate part has been inserted for certifying the amount of expenditure from year to year and the amended form No.3CL thus, lays down the procedure to be followed by the prescribed authority. Prior to the aforesaid amendment in 2016, no such procedure / methodology was prescribed. In the absence of the same, there is no merit in the order of Assessing Officer in curtailing the expenditure and consequent weighted deduction claim under section 35(2AB) of the Act on the surmise that prescribed authority has only approved part of expenditure in form No.3CL. We find no merit in the said order of authorities below. 46. The Courts have held that for deduction under section 35(2AB) of the Act, first step was the recognition of facility by the prescribed authority and entering an agreement between the facility and the prescribed authority. Once such an agreement has been executed, under which recognition has been given to the facility, then thereafter the role of Assessing Officer is to look into and allow the expenditure incurred on in-house R&D facility as weighted deduction under section 35(2AB) of the Act. Accordingly, we hold so. Thus, we reverse the order of Assessing Officer in curtailing the deduction claimed under section 35(2AB) of the Act by 6,75,000/-. Thus, grounds of appeal No. 10.1, 10.2 and 10.3 are allowed. 47. In the result, appeal of assessee is partly allowed." Since the facts of the case are similar to the AY 2014-15, the disallowance of Rs. 50,28,63,30/- is deleted based on the decision of the Hon'ble ITAT in the appellant's own case. Ground Nos. 1 and 2 are allowed.”
Dissatisfied by the order of the Ld.CIT(A)/NFAC in deleting the addition of Rs. 5,02,86,330/- made by the Ld.AO on account of disallowance of weighted deduction u/s. 35(2AB) of the Act, the Revenue is in appeal before the Tribunal raising the following grounds of appeal:
“1. Whether, on the facts & in the circumstances of the case, the Ld. CIT(A), NFAC, Delhi was justified in deleting the addition made by Assessing officer on account of disallowance of deduction u/s 35(2AB) of the Act amounting to Rs.5,02,86,330/-, claimed by the assessee but not allowed by the DSIR? 2. Whether, on the facts & in the circumstances of the case, the Ld. CIT(A), Aurangabad was justified in interpreting the provisions of section 35(2AB) of the Act read with Rule 6 of the Income Tax Rules 1962, by making reliance on the decision of Hon'ble ITAT Pune in the assessee's own case for AY 2014-15 (ITA No. 179/PUN/2018)? 3. Whether on the facts and in the circumstances of the case, the order of the AO deserves to be restored and that of the Ld. CIT(A), NFAC, Delhi be set aside? 4. The appellant craves leave to add, amend or alter all or any of the Grounds of Appeal.”
5 East West Seeds India Private Limited 5. The Ld. DR submitted that for AY.2014-15, Revenue has already preferred an appeal against the order of Tribunal (supra) before the Hon'ble High Court. Accordingly, the issue relating to allowability of weighted deduction u/s 35(2AB) of the Act, particularly in the context of DSIR approval and quantification as per Form No. 3CL is presently pending for adjudication before a higher judicial forum and the matter has not attained finality and remains sub-judice. Since, the identical issue arises in current assessment year and therefore, in order to maintain consistency and safeguard interest of Revenue, the Tribunal‟s order for AY. 2014-15 should not be followed.
The Ld.AR, on the other hand, strongly supported the order of the Ld.AO and submitted that the impugned issue is squarely covered in favour of the assessee in assessee‟s own case by the decision of the Tribunal (supra) for AY. 2014-15 and since the facts remain unchanged, the same should be followed and Revenue‟s appeal should be dismissed.
We have heard the Ld. Representatives of the Parties and perused the material available on record as well as the paper book filed by the Ld.AR on behalf of the assessee. The facts of the case are not in dispute. We find that based on the DSIR certificate in Form-3CL, the Ld.AO in the scrutiny assessment u/s. 143(3) of the Act, disallowed the expenditure of Rs. 5,02,86,330/- as not eligible for weighted deduction u/s. 35(2AB) of the Act. However, the Ld.AO allowed 100% of Rs. 5,02,86,330/- u/s. 35(1)(i)/37(1) of the Act. We find the Ld.CIT(A)/NFAC has deleted the said addition for the reasons which we have already reproduced in the preceding paragraphs, which is mainly on the ground that the claim of the assessee was allowed by the Tribunal for AY. 2014-15. We find that an identical issue had come up for consideration before the Tribunal in AY. 2014-15,
6 East West Seeds India Private Limited wherein the Tribunal dismissed the Revenue‟s appeal being devoid of any merit by observing as under: “5. Both sides heard. Orders of the authorities below perused. The solitary issue raised by the Revenue in appeal is against deleting the addition made on account of disallowance of deduction u/s. 35(2AB) of the Act. The assessee company is engaged in the business of production and procuring of vegetable, fruits and flower seeds from local as well as overseas market and sells them in Indian as well as export market. The assessee is also engaged in production and processing of hybrid seeds. The assessee has set up Research and Development facility to cater to the requirements of agricultural sector. The assessee claimed deduction u/s. 35(2AB) in respect of R & D facilities. The R & D center of the assessee is approved by DSIR. However, the claim of assessee was disallowed by the Assessing Officer on the ground that as against the assessee's claim of weighted deduction of Rs.9,85,70,330/-, the DSIR has approved Rs.6,25,52,000/-. The contention of the assessee is that during the period relevant to assessment year under appeal DSIR has no power to quantify the deduction claimed by assessee u/s. 35(2AB). The only requirement is the recognition of R & D facility by DSIR. We find that the issue raised in the appeal is squarely covered by the decision rendered in the case of Cummins India Ltd. Vs. Deputy Commissioner of Income Tax (supra). The Tribunal after considering various decisions has held as under: “45. The issue which is raised in the present appeal is that whether where the facility has been recognized and necessary certification is issued by the prescribed authonty, the assessee can avail the deduction in respect of expenditure incurred on in- house R&D facility, for which the adjudicating authority is the Assessing Officer and whether the prescribed authority is to approve expenditure in form No.3CL from year to year. Looking into the provisions of rules, it stipulates the filing of audit report before the prescribed authority by the persons availing the deduction under section 35(2AB) of the Act but the provisions of the Act do not prescribe any methodology of approval to be granted by the prescribed authority vis-à-vis expenditure from year to year. The amendment brought in by the IT (Tenth Amendment) Rules w.e.f. 01.07.2016, wherein separate part has been inserted for certifying the amount of expenditure from year to year and the amended form No.3CL thus, lays down the procedure to be followed by the prescribed authority. Prior to the aforesaid amendment in 2016, no such procedure / methodology was prescribed. In the absence of the same, there is merit in the order of Assessing Officer in curtailing the expenditure and consequent weighted deduction claim under section 35(2AB) of the Act on the surmise that prescribed authority has only approved part of expenditure in form No.3CL. We find no merit in the said order of authorities below. 46. The Courts have held that for deduction under section 35(2AB) of the Act, first step was the recognition of facility by the prescribed authority and entering an agreement between the facility and the prescribed authority. Once such an agreement has been executed, under which recognition has been given to the facility, then thereafter the role of Assessing Officer is to look into and allow the expenditure incurred in-house R&D facility as weighted deduction under section 35(2AB) of the Act. Accordingly, we hold so. Thus, we reverse the order of Assessing Officer in curtailing the deduction claimed under section 35(2AB) of the Act by 6,75,000/-. Thus, grounds of appeal No. 10.1, 10.2 and 10.3 are allowed. 47. In the result, appeal of assessee is partly allowed."
7 East West Seeds India Private Limited
We find that similar view was taken by the Co-ordinate Bench of Tribunal in the case of Bharat Forge Ltd. Vs. Addl. Commissioner of Income Tax (supra). 7. The Revenue has not placed on record any material to controvert the findings of Tribunal. Thus, after considering the undisputed facts of the case and the decisions of the Co-ordinate Bench on the issue, we uphold the findings of Commissioner of Income Tax (Appeals) in allowing assessee's claim of weighted deduction u/s. 35(2AB) of the Act. 8 In the result, the impugned order is upheld and the appeal of Revenue is dismissed being devoid of any merit.”
Undisputedly, the facts of the present case are identical to the facts in AY. 2014-15. Although the impugned issue is sub-judice and pending before the Hon‟ble High Court in the appeal filed by the Revenue, in the absence of any contrary material brought on record by the Revenue and respectfully following the decision of the Co-ordinate Bench of the Tribunal in assessee‟s own case for AY. 2014-15, we do not find any infirmity in the order of the Ld.CIT(A)/NFAC in allowing the assessee‟s claim of weighted deduction u/s. 35(2AB) of the Act. We, therefore, uphold the order of the Ld.CIT(A)/NFAC and dismiss the grounds raised by the Revenue.
In the result, the appeal of the Revenue is dismissed.
Assessee‟s appeal in ITA No. 962/PUN/2026 (AY. 2017-18):
Facts in brief are that the assessee filed its return of income for AY. 2017-18 on 23-11-2017 declaring total income of Rs. 13,10,54,370/-. The case of the assessee was selected for scrutiny under CASS. The assessee filed its response to statutory notices u/s. 143(2) and 142(1) of the Act from time to time submitting the information/details called upon by the Ld.AO. During the course of assessment proceedings, the Ld.AO noted that the assessee has claimed excess deduction u/s. 35(2AB) of the Act amounting to Rs. 6,54,53,994/- as against the expenditure approved by DSIR in Form- 3CL. He accordingly completed the assessment at Rs. 19,65,08,360/- thereby making the addition of Rs. 6,54,53,994/- to the income returned
8 East West Seeds India Private Limited by the assessee, vide his order dt. 16-04-2021 passed u/s. 143(3) r.w.s. 143(3A) and 143(3B) of the Act.
Aggrieved, the assessee filed an appeal before the Ld.CIT(A)/NFAC, challenging the above addition made by the Ld.AO. The Ld.CIT(A)/NFAC dismissed the ground raised by the assessee, observing as under: “6.0 I have carefully considered the assessment order, the grounds of appeal and the appellant's statement of facts along with the written submission filed and the judicial precedents relied upon. 6.1 Grounds No.1.1 to 1.3 - Disallowance under Section 35(2AB) 6.1.1 The dispute relates to the Assessing Officer's restriction of deduction under section 35(2AB) to the extent of expenditure approved by DSIR in Form No. 3CL. DSIR has approved only a part of the expenditure in Part-B of Form 3CL issued for the relevant year, and the Assessing Officer has allowed weighted deduction only to that extent. The appellant contends that Form 3CL is not binding and that the Assessing Officer ought to have allowed deduction on the entire actual expenditure, irrespective of DSIR certification. 6.1.2 The Pune Bench of the ITAT in Cummins India Ltd. v. DCIT has been relied upon by the appellant. However, the said decision is clearly distinguishable. In Cummins India (supra), the Tribunal allowed the assessee's claim only because the assessment year involved was prior to the amendment of Form 3CL w.e.f. 01.07.2016. The Tribunal specifically held that: "...prior to the aforesaid amendment in 2016, no such procedure /methodology was prescribed... in the absence of the same, there is no merit in the order of the Assessing Officer in curtailing the expenditure... on the surmise that prescribed authority had only approved part of the expenditure in Form 3CL." (para 45) 6.1.3 The Tribunal further emphasized that the amended Form 3CL- effective from 01.07.2016-introduced a specific mechanism for DSIR to certify year-wise eligible expenditure. 6.1.4 In the present case, the year under consideration is post- amendment, and the DSIR has, in accordance with the amended Form 3CL, certified only a part of the expenditure. Once the amended statutory scheme requires certification of expenditure year-wise by the prescribed authority, the Assessing Officer is bound by such certification. The Assessing Officer's role is confined to allowing weighted deduction only on the amount approved by DSIR. Other judicial precedents quoted by the appellant also pertain to years preceding the amendment. 6.1.5 The appellant's argument that the Rules cannot override the Act is misplaced because section 35(2AB) expressly empowers the Central Government to prescribe the form, manner, and conditions for approval, and Rule 6(7A) along with amended Form 3CL is issued pursuant to that statutory delegation. The DSIR's quantification of eligible expenditure is therefore integral to the statutory scheme. 6.1.6 Following the amended legal framework and distinguishing the decision in Cummins India Ltd. (supra) on facts and law, the Assessing Officer was justified in restricting the deduction under section 35(2AB) to the amount certified by DSIR. Accordingly, Grounds No.1.1 to 1.3 are dismissed.”
9 East West Seeds India Private Limited
Before the Ld.CIT(A)/NFAC, the assessee also raised an additional ground relating to refund of excess Dividend Distribution Tax (DDT) under applicable Double Taxation Avoidance Agreement (DTAA) and allowance of deduction of R&D expenses disallowed by DSIR u/s. 35(1)(iv) for capital expenditure and u/s. 37/35(1)(i) of the Act for revenue expenditure. The Ld.CIT(A)/NFAC, however, rejected all these additional grounds as not admissible by observing as under:
“...Under Rule 46A(1), additional evidence or new claims may be admitted at the appellate stage only under specific circumstances such as where the AO refused to admit evidence, where the appellant was prevented by sufficient cause from producing such material before the AO, or where the AO made the order without giving adequate opportunity. In the present case: The appellant has not demonstrated that any of the conditions prescribed under Rule 46A(1)(a)-(d) are satisfied. No contention has been made that the AO denied an opportunity or refused to admit evidence. The claims now raised require fresh factual verification, which is impermissible when Rule 46A(1) conditions are not met. Accordingly, since the additional grounds do not fall within the permissible exceptions under Rule 46A(1) and would necessitate fresh factual inquiry, the same cannot be admitted at this stage. The additional grounds are therefore rejected as not admissible. The AO may verify the claims regarding DDT refund and compute income and tax liability as per provisions of the Act. 7.0 The appeal is, therefore, dismissed.”
Dissatisfied, the assessee is in appeal before the Tribunal raising the following grounds of appeal: “1] The ld. CIT(A) erred in confirming the disallowance made u/s. 35(2AB) of Rs. 6,54,53,994/- by holding that the weighed deduction claimed by the assessee u/s. 35(2AB) was to be restricted to be claim certified by the DSIR in Form 3CL. 2] The ld. CIT(A) failed to appreciate that the claim made by the assessee u/s. 35(2AB) was justified in law and there was no reason to restrict the same to the amount certified by DSIR in form 3CL. 3] The ld. CIT(A) erred in dismissing the alternate ground raised by the assessee company that in case, the disallowance made u/s. 35(2AB) is upheld, the expenses incurred on the inhouse research by the assessee company and which have been disallowed by DSIR ought to be allowed as a deduction u/s. 35(1)(iv)/37(1) of the Act. 4] The ld. CIT(A) erred in rejecting the above claim of the assessee on the ground that the same was not made before the Id. A.O. and no reason for furnished for the omission of the same without appreciating that in case,
10 East West Seeds India Private Limited the revenue / capital expenses are disallowed by DSIR for the purposes of the weighted deduction u/s. 35(2AB), the same ought to have been allowed as a deduction u/s. 35(1)(iv)/37(1) of the Act and there was no reason to dismiss of the additional ground raised by the assessee company. 5] The ld. CIT(A) erred in not appreciating that the liability in respect of the DDT paid as per section 1150 ought to have been restricted as per the beneficial provisions of the DTAA between India and Netherlands and hence, the excess DDT paid of Rs. 56,43,868/- ought to have been refunded to the assessee company. 6] The ld. CIT(A) erred in not appreciating that the liability in respect of the DDT paid as per section 1150 ought to have been restricted as per the beneficial provisions of the DTAA between India and Thailand and hence, the excess DDT paid of Rs. 18,81,289/- ought to have been refunded to the assessee company. 7] The appellant craves leave to add, alter, amend or delete the above grounds of appeal.”
As regards ground Nos.1 & 2, the Ld.AR conceded that these grounds do not hold good in light of the amendment in the relevant provisions and therefore, these grounds may be dismissed. Accordingly, the disallowance made by the Ld.AO and confirmed by the Ld.CIT(A)/NFAC u/s. 35(2AB) of the Act is upheld. Ground Nos. 1 & 2 are dismissed.
14.1. As regards Ground Nos. 3 & 4, the Ld.AR submitted that the actual expenses incurred by the assessee on in-house R&D which have been disallowed by DSIR should alternatively be allowed as a deductible expense u/s. 35(1)(iv)/37(1) of the Act. Relying on the decision of the Co-ordinate Bench of the Tribunal in the case of DCIT vs. Indus Biotech limited in ITA No. 3307/PUN/2025 (AY. 2021-22), dt. 17-08-2026, he submitted that the issue may be set aside to the file of the Ld.AO with a direction to verify the assessee‟s claim and allow the deduction u/s. 35(1)(iv)/37(1) of the Act as a result thereof.
14.2. As regards Ground Nos. 5 & 6, the Ld.AR submitted that during AY. 2017-18, the assessee paid DDT @ 20.36% u/s. 115-O of the Act amounting to Rs. 1,10,92,854/- to East West International B.V., Netherlands and Rs. 36,97,618/- to East West Seed International Ltd.
11 East West Seeds India Private Limited Thailand whereas the applicable rate as per the relevant DTAAs of India with Netherlands and Thailand is 10%. The assessee has thus paid excess DDT amounting to Rs. 56,43,868/- and Rs. 18,81,289/- in respect of dividend paid by the assessee to East West International B.V., Netherlands and East West Seed International Ltd. Thailand respectively. Relying on the decision of the Co-ordinate Bench of the Tribunal in the case of Piaggio Vehicles Private Limited vs. ACIT in ITA No. 3195/PUN/2025, dt. 25-05- 2026, he submitted that the impugned issue now stands covered in favour of the assessee by the Hon‟ble Bombay High Court and thus, pleaded that the issue may be set aside to the file of the Ld.AO to verify the assessee‟s eligibility for claiming beneficial provisions of the relevant DTAAs and accordingly, allow refund of excess DDT paid by the assessee.
The Ld.DR, on the other hand, relied on the decision of the Ld.CIT(A)/NFAC.
We have heard the Ld. Representatives of the Parties and perused the material available on record and the paper book filed by the Ld.AR on behalf of the assessee. We have also perused the various judicial precedents relied upon by the Ld.AR. We find that in Ground Nos. 3 & 4 the Ld. Counsel for the assessee has raised an alternate contention that since the assessee has incurred the expenditure wholly for its R&D activities and therefore, such expenditure should be allowed as deduction u/s. 35(1)(iv)/37(1) of the Act even if the claim was inadmissible u/s. 35(2AB) of the Act. We find that the Ld.CIT(A)/NFAC has not adjudicated this ground (raised by way of an additional ground) by the assessee on the ground that the same do not fall within the permissible exception under Rule 46A(1) of the Income Tax Rules, 1962 and would necessitate fresh factual enquiry, the reasoning of which is already reproduced in the
12 East West Seeds India Private Limited preceding paragraphs. We find some force in the arguments advanced by the Ld. Counsel for the assessee and in our view, the assessee‟s claim would fall within the purview of section 35(1)(iv)/37(1) of the Act. It is worthy to mention that in the previous AY. 2016-17, the Ld.AO had himself allowed the assessee‟s claim of the entire R&D expenses u/s. 35(1)(i)/37(1) of the Act. We find that an identical issue had come up before the Tribunal in the case of DCIT vs. Indus Biotech Limited (supra) wherein the Tribunal dismissed the Revenue‟s appeal and allowed the assessee‟s claim of expenditure u/s. 35(1)(iv) of the Act by observing as under: “7. We have heard the Ld. Representatives of the Parties and perused the material available on record, the paper book(s) filed by the Ld.AR on behalf of the assessee and the judicial precedents relied upon by the Ld.AR. We find that the Ld.AO, vide his order dt. 27-12-2022 passed u/s.143(3) r.w.s. 144B of the Act assessed the total income of the assessee at Rs. 44,40,28,340/-, thereby disallowing the deduction amounting to Rs. 2,48,18,076/- claimed u/s.35(1)(iv) of the Act in respect of payment made to third parties for testing/clinical trials of the products. On appeal, the Ld.CIT(A)/NFAC allowed the assessee’s appeal on the impugned issue for the reasons which we have already stated in the preceding paragraphs. We find that the Ld.AO has disallowed the assessee’s claim primarily for the reason that the assessee has not furnished complete details about the research and development activities and evidences in support of payments made to the outside agencies/third parties for carrying out the testing/clinical trials. Rejecting the submission made by the assessee, the Ld.AO considered the assessee’s alternate plea raised on a without prejudice basis and proceeded to finalize the assessment by disallowing the in-house research and development expense amounting to Rs. 2,48,18,076/-. Before us, the Ld. Counsel for the assessee has submitted that the assessee had submitted all the relevant details/documents/evidences in support of its claim. From the documents placed on record, we find that the assessee had duly filed its submission before the Ld.AO, the relevant extract of which is reproduced below for ease of reference (pg. 84-86 of the paper book refers):
13 East West Seeds India Private Limited
14 East West Seeds India Private Limited
7.1. The above contention of the assessee is also supported by a copy of the e- filing acknowledgment of the reply filed by the assessee which is placed on record by the Ld.AR. This makes it abundantly clear that the clinical trial repots relevant to the scientific research under consideration were duly furnished by the assessee at the time of assessment proceedings itself. We find that the Ld.CIT(A)/NFAC while deleting the addition made by the Ld.AO, has considered the documents uploaded/submitted by the assessee in respect of payments made to the third parties and only after examining/considering the same, the Ld.CIT(A)/NFAC has taken a view that clinical trials/tests are related to the business carried on by the assessee and hence, the assessee is eligible to claim deduction u/s.35(1)(iv) of the Act. The Revenue is aggrieved that the assessee failed to furnish complete details about R&D activities and evidence of the capital expenditure and to substantiate
15 East West Seeds India Private Limited that expenditure incurred was actually in capital nature and related to the business carried on by the assessee. 7.2. In view of the discussion above, we do not find any merit in the contention of the Revenue. In our view, payment made to third parties for clinical trials/testing claimed as deduction u/s.35(1)(iv) of the Act forms an integral part of the in-house research and development activities carried out by the assessee. We also find force in the contention of the Ld.AR that expenditure of capital nature on scientific research related to the business carried on by the assessee is eligible for deduction u/s.35(1)(iv) of the Act. 7.3. We find that an identical issue had come up for consideration before the Hon’ble Karnataka High Court in the case of CIT vs. Talisma Corporation (P.) Ltd. (supra). The Hon’ble High Court decided the impugned issue in favour of the assessee and against the Revenue, holding as under:
“9. It is the specific case of the Revenue that, the amount of Rs. 10.82 crores spent by the assessee in acquiring an intellectual property is capitalized in the books. Now further amount of Rs. 9,27,34,277/- is spent in developing and improving the said product. Therefore, the expenditure on further development of software, which is treated as a capital in nature, is also capital in nature. This development is on account of scientific research. The evidence on record shows most of the money is spent towards cost of the employees, who had developed the product "Talisma Enterprise 2.5", multi channel customer relationship management solution, which provides sales, marketing, services, human resources and finance through the medium of e-mail, chat, wireless, fax, phone, etc. to the end users. Therefore, the expenditure in respect of the scientific research, even if it is capital in nature as it was incurred in relation to the business carried on by the assessee under section 35(1)(iv) of the Act, the said expenditure is to be deducted. That is what the Appellate Authority as well as the Tribunal have held. Accordingly, we answer the substantial questions of law in favour of the assessee and against the Revenue. In that view of the matter, we do not see any infirmity in the order passed by the Tribunal, which calls for interference. Hence, the appeal is dismissed."
7.4. We find that the Co-ordinate Bench of the Pune Tribunal in the case of Mahle Behr India (P.) Ltd. vs. DCIT (supra) has also allowed the assessee’s claim of capital expenditure incurred on scientific research u/s.35(1)(iv) of the Act. The relevant extract of the aforesaid decision is reproduced below: “15. In his alternate submission he submitted that the assessee has incurred expenses on Product testing and validation at Rs. 3,38,82,341/- outside India in the course of product development undertaken in approved in house R & D Centre. The said expenses were capitalised and consisted of Capitalised Development cost Rs.1,08,68,113/- and Capital WIP Rs.2,30,14,228/-, The DRP has denied claim for weighted deduction. The said testing and validation was carried out at the parent company's facilities in Germany and claim has been made u/s 35 (1) (iv) on the basis of incurrence of capital expenses. Proposition for claim u/s 35 (1) (iv) has been upheld by Hon'ble Gujarat High Court in CIT v. Gujarat Aluminium Extrusions (P.) Ltd. [2003] 133 Taxman 542/263 ITR 453 (Gujarat). Identical issue had come up before the Pune Bench of the Tribunal in assessee's own case for the preceding year A.Y. 2011-12 and on the backdrop of same set of facts the Tribunal has held that the said capital expenditure on R & D is eligible for 100% deduction u/s 35 (1) (iv) read with 35 (2) of the Act consequent to denial of claim u/s 35 (2AB). He submitted that in view of the above decisions, the issue stands covered in favour of the assessee.
16 East West Seeds India Private Limited
The Ld. DR on the other hand heavily relied on the orders of the Assessing Officer/TPO/DRP. 17. We have heard the rival arguments made by both the sides, perused the orders of the Assessing Officer /TPO/DRP and the paper book filed on behalf of the assessee. We have also considered the various decisions cited before us. We find an identical issue had come up before the Tribunal in assessee's own case for assessment year 2011-12. The Tribunal vide Mahle Behr India (P.) Ltd. v. Dy. CIT [2021] 130 taxmann.com 7/190 ITD 852 (Pune - Trib.) ITA No.624/PUN/2018, order dated 31.08.2021 has decided the issue in favour of the assessee by observing as under: 3. Succinctly, the facts of the case are that the assessee is engaged in manufacturing automobile accessories particularly Heat exchangers, ie. Radiators, Evaporators, Condensers and Automotive air conditioning systems. The return was filed declaring total income of Rs.3.56 crore and odd. One of the reported international transactions was Payment of Research and development expenses to three Associated enterprises (AEs) situated in the USA, Japan and Germany. The Assessing Officer (AO) made a reference to the Transfer Pricing Officer (TPO) for determining the arm's length price (ALP) of the international transactions. The TPO accepted the transaction of Payment of R&D expenses at ALP. In the computation of total income, the assessee had claimed weighted deduction u/s 35(2AB) of the Act amounting to Rs.26,73,42,263/- on Research and development expenses. The assessee was called upon to furnish details of such expenditure claimed as qualifying for the weighted deduction, which were filed. On perusal of such details, the Assessing Officer (AO) observed that the assessee claimed weighted deduction on Research and Development costs of Rs.9,61,80,237/-carried outside India. Rejecting the assessee's contention, the AO disallowed a sum of Rs.8,86,84,811/-, being, the amount of capital R&D expenditure incurred outside India. Aggrieved thereby, the assessee filed appeal before the Id. CIT(A), who, after issuing enhancement notice, held that the AO erred in allowing weighted deduction u/s.35(2AB) at a higher sum. He observed that the prescribed authority had restricted the amount of eligible deduction to the amount of expenditure incurred for the period 07- 12-2010 to 31-03-2011 to only Rs.1,32,39,000/- as per Form No. 3CL dated 08-07-2014. As the approval was granted w.e.f. 07-12- 2010, the Id. CIT(A) held that the assessee was not eligible for weighted deduction on the expenditure incurred from 01-04-2010 to 06-122010. He further held that any expenditure capitalized by the assessee in the nature of Intangibles was not eligible for the weighted deduction. The amount capitalized by the assessee was held to be eligible for depreciation allowance at 25%. To sum up, he allowed deduction for a sum of Rs.2,56,94,285/-(Rs. 1,32,39,000/- as permitted by the Prescribed authority u/s.35(2AB) plus depreciation @ 25% on the amount of capital expenditure of Rs.4,98,21,138/-. This resulted into enhancement of income by Rs.15,29,63,167/-, other than the confirmation of addition made by the AO. This has brought the assessee before the Tribunal. 4. We have heard both the sides and gone through the relevant material on record. The AO proceeded with allowing the weighted deduction on the basis of a Table submitted by the assessee, which has been
17 East West Seeds India Private Limited
It can be seen from the above Table that the assessee categorized R&D expenses under three broad heads: 'Considered in FA Additions' amounting to Rs.4,98,21,138/- (Sub-total A); 'Considered in CWIP amounting to Rs.6,67,82,591/- (Sub-total B); and Expenses Debited to P&L A/c' amounting to Rs.3,41,34,804/- (Sub-total C). The three heads have further been bifurcated into 'Outside India' and 'Remaining inside India. Total of three expenses incurred outside India comes to Rs.9,61,80,237. As the aggregate Sub-total C was claimed as revenue expenditure in Profit and Loss account, the assessee claimed deduction u/s 35(2AB) at two times of the aggregate Sub-totals (A) and (B) and one time of the aggregate Sub-total C for a total sum of Rs.26,73,42,263/-. Against such a claim of the assessee, the AO disallowed a sum of Rs.8.86 crore, being, the weighted part of sub-totals (A) and (B) of the expenditure incurred outside India, thereby allowing a single unweighted deduction of such costs incurred outside India. The Id. CIT(A) further disallowed even the one time of the amount of the revenue expenses allowed by the AO and also sub-totals (A) & (B) except for granting depreciation allowance on the amount considered by the assessee in FA additions amounting to Rs.4,98,21,138/-. Thus, the Id. CIT(A) allowed total weighted deduction of Rs.2.57 crores by primarily relying on the amount approved by the Prescribed authority (DSIR) with effect from the date of approval, namely, 07-12-2010 and also a limited amount of depreciation allowance. A copy of the approval has been placed at page 25A of the paper book, which is letter dated 0712-2010 issued by the DSIR recognizing the assessee's in-house R&D unit. 6. The case of the ld. CIT(A) is that the assessee was not eligible for weighted deduction on any amount spent by it on a date prior to the grant of approval. For this purpose, he relied on Guidelines of in-house R&D centres recognized by DSIR issued in May, 2010. The relevant part of the guidelines given in para 6-Policy for approval is as under: "(1) Approval to the in-house R&D centres having valid recognition by DSIR are considered from 1st April of the year in which application is made Form 3CK. (ii) Approval is considered co-terminus with DSIR recognition. (iii) For companies not having DSIR recognized in-house R&D Centre, approval is considered from the date of recognition. 7. The remaining 3 points given as (vi) to (vi) under the Policy approval apply only in case of firms. The assessee is a company which is governed by first three clauses of para 6 of the Policy for approval. Clause (1) clearly states that approval to the in-house R&D centres having valid recognition by DSIR are considered from 1st April of the year in which application is made in Form 3CK. The assessee in the instant case filed application on 15-07-2010 whose copy is available at page 26 to 66 of the paper book.
18 East West Seeds India Private Limited Pursuant to the assessee's application, it was accorded recognition vide letter issued by DSIR on 07-122010. Going with the mandate of clause (1) of para 6 of the Guidelines as extracted above, the approval will have to be considered from 1st April of 2010, which is the previous year relevant to the assessment year under consideration. Clause (iii) providing for the approval to be considered from the date of recognition, applies only in case of companies not having DSIR recognized inhouse R&D. Since the assessee has a valid approval granted by the DSIR for R&D Centre, it is covered within the four walls of clause (i) and there is no scope for applying clause (iii) and accordingly making it eligible for deduction only from the date of recognition. Accordingly, it is held that the approval to the assessee's in-house R&D centre is to be considered from 1st April of 2010 under the above clause (i). The view point of the ld. CIT(A) considering the expenditure only from the date of the approval, namely, 07-12-2010, in our considered opinion is not in accordance with the relevant rules. This portion of the impugned order is thus vacated. 8. The ld. CIT(A) restricted the claim of weighted deduction to the amount of Rs.1,32,39,000/-, being, the amount permitted by the Prescribed authority. For this, he relied on Rule 6(7A) as applicable from 01-07-2016. Clause (b) of Rule 6 (7A) provides as under: "(b) The prescribed authority shall furnish electronically its report - (1) In relation to the approval of in-house research and development facility in Part A of Form No.3CL; (ii) quantifying the expenditure incurred on in-house research and development facility by the company during the previous year and eligible for weighted deduction under sub-section (2AB) of section 35 of the Act in Part B of Form No. 3CL;'. 9. Sub-Clause (1) of clause (b) of Rule 6 (7A) provides that the prescribed authority shall furnish its report in relation to the approval of in-house R&D facility quantifying the amount of expenditure incurred during the previous year, which is eligible for weighted deduction under sub-section (2AB) of section 35. It is on the basis of the above sub-clause (ii) of clause (b) of Rule 6(7A) that the ld. CIT(A) opined that the quantification of the expenditure incurred on in-house R&D facility has to be done by the prescribed authority and the amount eligible for weighted deduction cannot cross that threshold. It is no doubt true that subclause (ii) of clause (b) of Rule 6 (7A) categorically provides that the amount of weighted deduction u/s.35(2AB) has to be restricted to the amount quantified by the prescribed authority. However, it is relevant to note that the clause (b) as extracted above has been substituted by the Income- tax (10th Amendment) Rules, 2016 w.e.f. 01-07-2016. Prior to this substitution, the clause (b) read as under: "(b) The prescribed authority shall submit its report in relation to the approval of in-house Research and Development facility in Form No.3CL to the Director General (Income-tax Exemptions) within sixty days of its granting approval." 10. As per the pre-existing clause (b), the prescribed authority was supposed to submit only its report in relation to the approval of in- house R&D facility to the Director General (Income-tax Exemptions). The stipulation of quantifying the eligible expenditure by the competent authority for the purposes of weighted deduction u/s 35(2AB) was not there. The only requirement was to submit the report in relation to the approval of in-house R&D facility. Any amount of expenditure incurred in respect of in-house R&D facility qualified for the deduction whether or not approved by the prescribed authority. Only the existence of approval and incurring of
19 East West Seeds India Private Limited the expenditure were relevant considerations in the pre-amended era and not the amount quantified by the prescribed authority. The new stipulations came to be introduced w.e.f. 01-072016. As the assessment year under consideration is 2011-12 and the approval was granted by DSIR on 07-12-2010, the amended sub-clause (b) of Rule 6 (7A) coming into vogue even after the passing of the assessment order can have no applicability. We, therefore, hold that the Id. CIT(A) was not justified in restricting the amount of weighted deduction to the quantification done by the prescribed authority. The impugned order is reversed on this score. 11. The ld. CIT(A) also held that the capital expenditure in the nature of Intangibles incurred by the assessee could not qualify for the weighted deduction. For this purpose, he relied on the 'Guidelines for approval in Form 3CM of inhouse R&D Centres recognized by DSIR' dated May 2014. Para 4 of such Guidelines contains 'Conditions subject to which approval is given. Clause (xi) of para 4 runs as under: "Capital expenditure on R&D, eligible for weighted deduction will include only plant and equipment or any other tangible item. Capitalized expenditure of intangible nature will not be eligible for weighted deduction." 12. It can be seen from the above that the capital expenditure of intangible nature has been made ineligible for the weighted deduction. However, it is crucial to note that this ineligibility has been introduced by means of Guidelines issued in May 2014. The predecessor Guidelines of May 2010 did not contain any clause similar to clause (xi) of the 2014 Guidelines. Since the assessment year under consideration is 2011-12, the Guidelines issued in May, 2014 can have no application to the case. We, therefore, overturn the impugned order on this score. 13. Now we come to the expenditure incurred outside India for which the assessee raised a claim of weighted deduction u/s.35(2AB) that was not allowed by the AO. The Id. AR claimed that the assessee was entitled to such deduction, which contention was strongly countered by the Id. DR. In order to appreciate the rival contentions, it would be befitting to have a glance at the relevant part of section 35(2AB) which is as under: "(2AB)(1) Where a company... incurs any expenditure on scientific research (not being expenditure in the nature of cost of any land or building) on in-house research and development facility as approved by the prescribed authority, then, there shall be allowed a deduction of a sum equal to... of the expenditure so incurred: Provided..." 14. A cursory look at the above provision deciphers the conditions for the weighted deduction, inter alia, that an eligible company incurs any expenditure on scientific research (other than cost of land or building) on in-house research and development facility as approved by the prescribed authority. The key words in the provision are incurring of expenditure on in-house R&D facility as approved by the prescribed authority. Unless a particular R&D facility is approved by the prescribed authority, no weighted deduction can follow. On a pertinent query, the ld. AR admitted that the prescribed authority approved the inhouse R&D unit of the assessee situated at "Gat No.626/1/2 and 622/1/0, 26 Milestone, Pune-Nasik Highway, Village Kuruli, Tal: Khed, District Pune". On a further query, the ld. AR submitted that the assessee's approved R&D facility was engaged in designing and developing of Engine cooling systems and HVAC systems for vehicles. During the designing and development phase, engine coolant and HVAC systems are required to be put in
20 East West Seeds India Private Limited Performance Evaluation Testing in variant weather conditions artificially created, for which sophisticated technology and set up is required that is not available in India. It was for such Performance Evaluation Test under variant weather conditions artificially created that the assessee availed services from its three AEs situated abroad. It was pointed out that the three AEs conducted the needful tests for which the assessee incurred total cost of Rs.9.61 crore tabulated under Column "Outside India", which was accepted by the TPO at ALP. 15. From the above discussion, it is abundantly clear that the total sum of Rs.9.61 crore incurred by the assessee outside India has not been incurred on inhouse R&D facility as approved by the prescribed authority. What to talk of inhouse R&D facility of the assessee approved by the prescribed authority, here is a case in which the assessee incurred these costs for availing services from the R&D facilities of its AEs. Since the R&D facilities for which the assessee incurred costs outside India are neither of the assessee nor approved by the prescribed authority, there can be no question of granting any weighted deduction on the expenses incurred outside India. To sum up, it is held that the assessee is entitled to weighted deduction u/s 35(2AB) on total amount of expenditure incurred in India amounting to Rs5,45,58,297. Resultantly, no weighted deduction is admissible in respect of expenditure incurred butside India amounting to Rs.9,61,80,237/- 16. At this juncture, it is pertinent to note the mandate of section 35 with the caption Expenditure scientific research. Clause (iv) of section 35(1) provides for deduction of expenditure on scientific nature "in respect of any expenditure of a capital nature on scientific research related to the business carried on by the assessee, such deduction as may be admissible under the provisions of sub-section (2)." Sub- section (2) of section 35, in turn, provides through sub-clause (ia) that for the purposes of clause (iv) of sub-section (1): 'in a case where such capital expenditure is incurred after the 31 day of March, 1967, the whole of such capital expenditure incurred in any previous year shall be deducted for that previous year". The proviso provides for not allowing deduction in respect of expenditure incurred on acquisition of any land. On a conjoint reading of section 35(1) (iv) read with section 35(2), it is manifested that any expenditure of capital nature incurred on scientific research, other than the cost of land etc., qualifies for full one time deduction in the year of such incurring. Unlike sub-section (2AB), sub-section (1) does not require any specific approval from the prescribed authority for this purpose. Further, there is no stipulation that the expenditure should be incurred in India or outside or in-house R&D facility or otherwise, save and except as provided in other clauses of sub-section (1) of section 35. However, the amount of deduction u/s.35(1) is equal to the amount of capital expenditure on scientific research. 17. Coming back to the amount of expenditure incurred by the assessee outside India amounting to Rs.9,61,80,237/-, we find that the expenditure of revenue nature, namely, Rs.74,95,427/- was claimed by the assessee as revenue expenditure and accordingly allowed also. It is only the remaining capital expenditure of Rs.8,86,84,811/- [Rs.3,39,60,518/- being sub-total (A) and Rs.5,47,24,293/- being sub-total (B)] that qualifies for deduction u/s.35(1)(iv). We order accordingly. 18. The ld. DR took strong exception to the claim of the Id. AR for granting deduction of the capital expenditure on scientific research and development incurred outside India u/s.35(1)(iv). He submitted that no such ground has been taken by the assessee. It is apparent that the assessee raised a claim for weighted deduction on such an amount u/s.35(2AB) of the Act. We have held hereinabove that the
21 East West Seeds India Private Limited amount does not qualify for the weighted deduction. The fact that the claim of the assessee cannot be entertained under one provision does not oust it from consideration under any other provision, if it is otherwise allowable under such latter provision. We have noticed that the amount of capital expenditure incurred on research and development outside India is eligible for deduction u/s.35(1)(iv). The same, therefore, has to be allowed as such. The Id. DR's contention in this regard is sans merit and hence repelled. 19. To summarize, the entire amount of R&D expenditure incurred in India is eligible for weighted deduction u/s 35(2AB); revenue R&D expenditure incurred outside India as claimed by the assessee got allowed in the assessment itself; total of capital R&D expenditure incurred outside India will be eligible for deduction u/s 35(1)(iv) of the Act." 18. Respectfully following the decision of the Co-ordinate Bench of the Tribunal in assessee's own case, we hold that the entire amount of R&D expenditure incurred in India is eligible for weighted deduction u/s 35(2AB); revenue R&D expenditure incurred outside India as claimed by the assessee got allowed in the assessment itself; total of capital R&D expenditure incurred outside India will be eligible for deduction u/s 35(1)(iv) of the Act. 19. In the result, the appeal filed by the assessee is allowed.” 7.5. We find that similar view has been taken by the Delhi Tribunal in the case of Escorts Ltd. vs. ACIT (supra), wherein the Tribunal dismissed the Revenue’s appeal on the impugned issue, by observing as under: 126. Ground No. 8 of the grounds of appeal of the Revenue is as under: On the facts and in the circumstances of the case and in law, the CIT(A) has erred in deleting the disallowance of Rs. 41,48,896 made by the AO on development of existing products ignoring that such expenditure imparted a benefit of enduring nature and as such was of capital nature. The CIT(A) also ignored that the assessee had separately claimed deduction under Section 35(1) (iv) of Rs. 23,93,88,410 as capital R&D expense and treated this expenditure of Rs. 41,48,896 only as pre- operative expense. 127. The said ground taken by the Revenue is against the action of the CIT(A) in deleting the disallowance of Rs. 41,48,896 made by the AO representing expenditure on development of existing products of the assessee-company. The facts are that the assessee had claimed in its return of income the impugned expenses on its R&D activity undertaken to improve the quality of its products. The AO rejected the claim and held that the expenditure was capital in nature on the ground that it resulted in imparting of enduring benefits to the assessee-company. In appeal before the CIT(A), the assessee contended that it has got R&D division which continuously undertakes research activity, and that the impugned expenditure has been incurred consistently even in the earlier assessment years. That no disallowance was made in any of the assessment years on this count. The CIT(A), after considering the facts and the pleas of the assessee, allowed the claim of the assessee for treating the impugned expenditure as revenue expenditure. The CIT(A) found that even if the expenditure was to be considered as a capital expenditure, yet the same being in the nature of R&D expenditure, it was an allowable deduction in terms of Section 35(1)(iv) of the Act. Revenue is presently in appeal against the aforesaid finding of the CIT(A). 128. Before us, the learned Departmental Representative has relied on the order of the AO in support of her submissions. The learned Counsel appearing on behalf of the assessee has defended the orders of the CIT(A) reiterating the submissions made before the lower authorities. Our attention was invited to p. 113 of the assessee's paper book with regard to the details of expenditure. It is submitted that the impugned
22 East West Seeds India Private Limited expenditure has been incurred by the assessee in its engineering division in relation to various products being manufactured namely, tractors, agricultural machinery, etc. 129. Having considered the rival submissions and the orders of the lower authorities with reference to the material on record, in our view, the conclusion drawn by the CIT(A) is justified on facts and in law. Insofar as the nature of expenditure is concerned, there is no dispute that the same relates to the developmental activities carried out by the assessee in its R&D division. The question whether the expenditure is revenue or capital, loses its significance while considering its deductibility because the nature of expenditure is on account of Research and Development. In terms of Clause (iv) of Sub-section (1) of Section 35, any expenditure, being in the nature of capital expenditure incurred on research related to the business carried on by the assessee, is an admissible deduction. Admittedly, the impugned research and development expenditure in question has been found by the CIT(A) to be related to the business of the assessee of manufacturing agricultural tractors, agriculture machinery, etc., a fact situation not controverted by the Revenue. Thus, it qualifies to be deductible under Section 35(1)(iv) of the Act. We do not find anything on record to conclude differently than the CIT(A). Thus, the expenditure has been rightly held to be deductible by the CIT(A). The said ground of the Revenue stands accordingly dismissed.”
7.6. Based on the factual matrix of the case and legal position set out above, and in the absence of any contrary material/judicial precedents brought on record by the Revenue, in our view, there is hardly any substance in the grounds of appeal raised by the Revenue. We do not find any infirmity in the order of the Ld.CIT(A)/NFAC which we hereby confirm. Accordingly, the grounds raised by the Revenue are dismissed. 8. In the result, the appeal filed by the Revenue is dismissed.”
In view of the factual matrix of the case and the decision of the Co-ordinate Bench of the Tribunal (supra) and in the absence of any contrary material/judicial precedent brought on record by the Revenue, in our view, the assessee is eligible for its claim u/s. 35(1)(iv)/37(1) of the Act. However, the claim of the assessee needs verification. Accordingly, the impugned issue is restored to the file of the Ld.AO to verify the assessee‟s claim and allow the same, as a result of such verification thereof. The Ground Nos. 3 & 4 are thus allowed in above terms.
Now, coming to Ground Nos. 5 & 6 pertaining to the assessee‟s claim of refund of excess dividend paid by it to East West International B.V., Netherlands and East West Seed International Ltd., Thailand under the beneficial provisions of India-Netherlands and India-Thailand DTAA respectively. The facts on this issue are not disputed. We find that an
23 East West Seeds India Private Limited identical issue had come up before the Co-ordinate Bench of the Tribunal in the case of Piaggio Vehicles Private Limited vs. ACIT (supra), wherein the Tribunal in turn relying on the decision of the Hon‟ble Bombay High Court in the case of M/s. Colorcon Asia Pvt. Ltd. in Tax Appeal No. 5 of 2024, dt. 28-11-2025, allowed the assessee‟s claim of refund of excess DDT paid under the beneficial provisions of the applicable DTAA therein, by observing as under:
24 East West Seeds India Private Limited
25 East West Seeds India Private Limited
In view of the factual matrix of the case and the decision of the Co-ordinate Bench of the Tribunal (supra) and in the absence of any contrary material/judicial precedent brought on record by the Revenue, in our view, the assessee is eligible for its claim of refund of excess DDT paid by it in respect of dividend paid to East West International B.V., Netherlands and East West Seed International Ltd., Thailand under the beneficial provisions of India-Netherlands and India-Thailand DTAA respectively. However, the claim of the assessee needs verification. Accordingly, the impugned issue is restored to the file of the Ld.AO to verify if the assessee is eligible for beneficial provisions under the respective India-Netherlands and India-Thailand DTAA and allow the assessee‟s claim of refund, as a result of such verification thereof. The Ground Nos. 5 & 6 are thus allowed in above terms.
In the result, the appeal filed by the assessee is partly allowed in above terms.
Assessee‟s appeal in ITA No. 963/PUN/2026 (AY. 2018-19): 21. In the present appeal, the assessee has raised the following grounds of appeal:
“1] The ld. CIT(A) erred in confirming the disallowance made u/s. 35(2AB) of Rs. 6,18,69,403/- by holding that the weighed deduction claimed by
26 East West Seeds India Private Limited the assessee u/s. 35(2AB) was to be restricted to be claim certified by the DSIR in Form 3CL. 2] The ld. CIT(A) failed to appreciate that the claim made by the assessee u/s. 35(2AB) was justified in law and there was no reason to restrict the same to the amount certified by DSIR in form 3CL. 3] The ld. CIT(A) erred in dismissing the alternate ground raised by the assessee company that in case, the disallowance made u/s. 35(2AB) is upheld, the expenses incurred on the inhouse research by the assessee company and which have been disallowed by DSIR ought to be allowed as a deduction u/s. 35(1)(iv)/37(1) of the Act. 4] The ld. CIT(A) erred in rejecting the above claim of the assessee on the ground that the same was not made before the Id. A.O. and no reason for furnished for the omission of the same without appreciating that in case, the revenue / capital expenses are disallowed by DSIR for the purposes of the weighted deduction u/s. 35(2AB), the same ought to have been allowed as a deduction u/s. 35(1)(iv)/37(1) of the Act and there was no reason to dismiss of the additional ground raised by the assessee company. 5] The appellant craves leave to add, alter, amend or delete the above grounds of appeal.”
Both the parties have unanimously conceded that the facts and the issues raised in the present appeal are identical to the facts and the issues raised in appeal in ITA No. 962/PUN/2026 for AY. 2017-18, except the variance of amounts mentioned therein. Since we have already decided the impugned issues in the preceding paragraphs in the appeal for AY. 2017- 18, following the similar reasoning, we dismiss Ground Nos. 1 & 2 raised by the assessee and allow Ground Nos. 3 & 4 on similar terms.
In the result, the appeal filed by the assessee is partly allowed in above terms.
In the nutshell, Revenue‟s appeal in ITA No. 961/PUN/2026 is dismissed and both the assessee‟s appeals in ITA Nos. 962 & 963/PUN/2026 are partly allowed in above terms. Order pronounced in the open Court on 05-11-2026
Sd/- Sd/- (RAMA KANTA PANDA) (ASTHA CHANDRA) VICE PRESIDENT JUDICIAL MEMBER पुणे/Pune; दिन ांक/Dated : 05-11-2026 TNMM
27 East West Seeds India Private Limited
आिेश की प्रदिदिदप अग्रेदिि / Copy of the Order is forwarded to: 1. अपीि र्थी / The Appellant 2. प्रत्यर्थी / The Respondent 3. The concerned Pr.CIT 4. DR, ITAT, „A‟ Bench, Pune 5. ग र्ड फ ईि / Guard file. आदेशानुसार/ BY ORDER, Sunil Digitally signed by // True Copy // Sunil Kumar More Kumar Date: 2026.11.16 Assistant Registrar More आयकर अपीिीय अदिकरण ,पुणे 15:49:04 +05'30' / ITAT, Pune
More judgments on Section 35(2AB)
- Skanray Technologies Limited, Mysuru vs DCIT, Central Circle-2(3), BangaloreITA 1247/BANG/2025[2019-20]Status: Disposed6 Nov 2026AY 2019-20
- Skanray Technologies Limited, Mysuru vs DCIT, Central Circle-2(3), BangaloreITA 1246/BANG/2025[2018-19]Status: Disposed6 Nov 2026AY 2018-19
- Skanray Technologies Limited, Mysuru vs DCIT, Central Circle-2(3), BangaloreITA 1245/BANG/2025[2017-18]Status: Disposed6 Nov 2026AY 2017-18
- Skanray Technologies Limited, Mysuru vs DCIT, Central Circle-2(3), BangaloreITA 1244/BANG/2025[2016-17]Status: Disposed6 Nov 2026AY 2016-17
- Skanray Technologies Limited, Mysuru vs DCIT, Central Circle-2(3), BangaloreITA 1243/BANG/2025[2015-16]Status: Disposed6 Nov 2026AY 2015-16
Recent GST High Court judgments
Search GST case law →- Kamdhenu Udyog Private Limited And Anr vs. The Assistant Commissioner Of Revenue Office Of The Charge Office, CT, Bhabanipur Charge And OrsCalcutta · 12 Nov 2026
- Keshab Joshi vs. State Of West Bengal And Ors.Calcutta · 12 Nov 2026
- Binayak Nayak vs. The Assistant Commissioner, GST And Central Excise, BbsrOrissa · 12 Nov 2026
- M/S Sunil Kumar Agrawal LLP, Raipur vs. State Of OdishaOrissa · 12 Nov 2026
- Life Insurance Corporation Of INDIA vs. The Insurance Ombudsman And 2 OrsGauhati · 11 Nov 2026